Lamivudine

NDC 31722-752 · Camber Pharmaceuticals, Inc.

Generic nameLamivudine

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)LAMIVUDINE

Strength100 mg/1

Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]

Marketing categoryANDA

Packages

31722-752-06 — 600 TABLET, FILM COATED in 1 BOTTLE (31722-752-06)

31722-752-31 — 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-752-31)

31722-752-32 — 100 TABLET, FILM COATED in 1 CARTON (31722-752-32)

31722-752-60 — 60 TABLET, FILM COATED in 1 BOTTLE (31722-752-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0006-5007 — doravirine, lamivudine, and tenofovir disoproxil fumarate, 0904-6583 — lamivudine, 31722-001 — lamivudine, 31722-506 — LAMIVUDINE and ZIDOVUDINE, 31722-739 — Lamivudine and Zidovudine, 31722-753 — Lamivudine, 31722-754 — Lamivudine, 31722-838 — ABACAVIR and LAMIVUDINE, 33342-001 — Lamivudine, 33342-002 — Lamivudine, 33342-003 — Lamivudine and Zidovudine, 33342-440 — Abacavir and Lamivudine, 42385-928 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-929 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 42385-962 — Abacavir and Lamivudine, 43063-900 — LAMIVUDINE and ZIDOVUDINE, 49502-450 — Lamivudine and Tenofovir Disoproxil Fumarate, 49502-475 — Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate, 49702-202 — lamivudine and zidovudine, 49702-203 — lamivudine, +32 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.